Teva Pharmaceutical Industries Limited
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Material agreementSep 16 →InsidersNo open-market buys. 12 insiders sold $96.3M, 28 of 47 sales on a 10b5-1 plan.→HoldersBlackRock 5.0%Phoenix Financial 3.4%WCM 3.3%→PeersClosest companies: AMGN, LLY, PFE→
From the filings
Figures
- Revenue
- $14.10Blast 12 months
- Net income
- $706.0Mlast 12 months
- Operating cash flow
- $1.90Blast 12 months
- Cash and equivalents
- $3.65Bat the last balance sheet
- Total debt
- $4.50Bat the last balance sheet
- Shares outstanding
- 1.27B shareson issue